Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Quitkin, F. M. Articles by Klein, D. Search for Related Content PubMed Citation Articles by Quitkin, F. M. Articles by Klein, D. Antidepressants

When Should a Trial of Fluoxetine for Major Depression Be Declared Failed?

OBJECTIVE: Although the newer antidepressants are widely used, little is known about how long it takes to see their full effect. The authors sought to determine how many weeks a fluoxetine trial with no improvement should continue before treatment is changed. METHOD: The data involved 840 patients in a 12-week open trial of fluoxetine, 20 mg/day, followed by a blinded, placebo-controlled discontinuation study. Outcomes at 4, 6, 8, 10, and 12 weeks were classified as nonresponse, partial response, response, and remission and were based on Hamilton Depression Rating Scale scores. The rate of remission at week 12 was calculated for each group of patients without remission at the earlier time points. The time to relapse during weeks 13–26 of the discontinuation study was examined in patients taking placebo and fluoxetine in relation to status at week 6. RESULTS: Patients unimproved at week 6 had a remission rate at week 12 of 31%–41%. For patients with remission at week 12, level of improvement at week 6 did not affect prognosis in weeks 13–26. Of the unimproved patients at week 8, 23% had remissions by week 12. The week 12 remission rate for unimproved patients at week 4 was clearly high enough to justify continued treatment; the rate for unimproved patients at week 10 was too low. CONCLUSIONS: These data suggest that nonresponse to fluoxetine should not be declared until 8 weeks of treatment have elapsed. Practitioners should discuss trial length with patients at the beginning of treatment.

This article has been cited by other articles:

				I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines J Psychopharmacol, June 1, 2008; 22(4): 343 - 396. [Abstract] [PDF]

				I. D. Glick, C. Salzman, B. M. Cohen, D. F. Klein, C. Moutier, H. A. Nasrallah, D. Ongur, P. Wang, and S. Zisook Improving the Pedagogy Associated With the Teaching of Psychopharmacology Acad Psychiatry, June 1, 2007; 31(3): 211 - 217. [Abstract] [Full Text] [PDF]

				S. Heres, W. Kissling, and S. Leucht Review: little evidence to support dose escalation of selective serotonin reuptake inhibitors in non-responders Evid. Based Ment. Health, May 1, 2007; 10(2): 46 - 46. [Full Text] [PDF]

				H. G. RUHE, J. HUYSER, J. A. SWINKELS, and A. H. SCHENE Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: Systematic review The British Journal of Psychiatry, October 1, 2006; 189(4): 309 - 316. [Abstract] [Full Text] [PDF]

				A. C. M. Vergouwen Initial rate of improvement in major depression The British Journal of Psychiatry, August 1, 2006; 189(2): 189 - 189. [Full Text] [PDF]

				J. A. Israel Remission in depression: definition and initial treatment approaches. J Psychopharmacol, May 1, 2006; 20(3 Suppl): 5 - 10. [Abstract] [PDF]

				S. Kasper, H. de Swart, and H. Friis Andersen Escitalopram in the Treatment of Depressed Elderly Patients Am J Geriatr Psychiatry, October 1, 2005; 13(10): 884 - 891. [Abstract] [Full Text] [PDF]

				H. Kavirajan Venlafaxine and SSRI remission data revisited The British Journal of Psychiatry, May 1, 2004; 184(5): 452 - 453. [Full Text] [PDF]

				How Long Is Long Enough for a Trial of Fluoxetine in Major Depression? Journal Watch Women's Health, June 17, 2003; 2003(617): 10 - 10. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us